Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
3.130
+0.080 (2.62%)
Mar 24, 2026, 4:00 PM EDT - Market closed
CPIX Employees
Cumberland Pharmaceuticals had 93 employees as of December 31, 2025. The number of employees increased by 2 or 2.20% compared to the previous year.
Employees
93
Change (1Y)
2
Growth (1Y)
2.20%
Revenue / Employee
$478,725
Profits / Employee
-$30,496
Market Cap
46.81M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 93 | 2 | 2.20% |
| Dec 31, 2024 | 91 | 0 | - |
| Dec 31, 2023 | 91 | 6 | 7.06% |
| Dec 31, 2022 | 85 | 2 | 2.41% |
| Dec 31, 2021 | 83 | -7 | -7.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 320 |
| Zhengye Biotechnology Holding | 277 |
| Rockwell Medical | 244 |
| Aytu BioPharma | 83 |
| BioXcel Therapeutics | 37 |
| SCYNEXIS | 18 |
| Talphera | 13 |
| Incannex Healthcare | 12 |
CPIX News
- 7 days ago - Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting - PRNewsWire
- 21 days ago - CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH - PRNewsWire
- 27 days ago - Joint U.S. Commercialization of RedHill's Talicia® Commences - PRNewsWire
- 27 days ago - CUMBERLAND PHARMACEUTICALS LAUNCHES U.S. PROMOTION OF TALICIA® - PRNewsWire
- 4 weeks ago - CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE - PRNewsWire
- 6 weeks ago - Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program - PRNewsWire
- 3 months ago - CALDOLOR® (IBUPROFEN) INJECTION CMS ISSUED J-CODE NOW ASSOCIATED WITH REIMBURSEMENT PRICE SUPPORTING NON-OPIOID PAIN MANAGEMENT - PRNewsWire
- 5 months ago - CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH - PRNewsWire